Roche announces positive interim results for emicizumab in phase III study of children with haemophilia A
Basel, 17 April 2017 Roche announces positive interim results for emicizumab in phase III study of children with haemophilia A Emicizumab prophylaxis reduced the number of bleeds in children with haemophilia A and inhibitors to factor VIII Results build upon data for emicizumab in adults and adolescents with haemophilia A and inhibitors to factor VIII... Read more